Breviscapine composition nano-particle and preparation method thereof
A breviscapine and nanoparticle technology, applied in the field of medicine, can solve the problems of reducing the effect of micronization, large surface free energy of the drug, neglecting the microstructure of the product, etc., and achieves high drug loading, in vivo bioavailability improvement, solvent remove full effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Mix breviscapine (33%), polyethylene glycol 40 hydrogenated castor oil (5%), copovidone (42%), polyacrylic acid resin (20%), stir in absolute ethanol for 2 hours at room temperature to dissolve , the mass volume fraction of the polymer is 6%, and when the solution is clear, it is transferred to the needle tube, the needle diameter is 0.5mm, the ambient temperature is 25°C, the humidity is controlled below 40%, and the pushing speed of the push pump is 4mL / h. The distance is 20cm, and 15kV high-voltage static electricity is applied between the needle and the steel plate for electrostatic spraying, and the obtained nanoparticles are collected on the steel plate. The obtained breviscapine composition nanoparticles were vacuum-dried for 1 h to completely remove the solvent.
Embodiment 2
[0032] Mix breviscapine (55%), vitamin E polyethylene glycol succinate (10%), copovidone (15%), and polyacrylic resin (20%), stir in absolute ethanol for 2 hours at room temperature to dissolve , the mass volume fraction of the polymer is 6%, when the solution is clear, transfer it to the needle tube, the needle diameter is 0.8mm, the ambient temperature is 25°C, the humidity is controlled below 40%, and the push speed of the push pump is 2mL / h. The distance is 20cm, and 15kV high-voltage static electricity is applied between the needle and the steel plate for electrostatic spraying, and the obtained nanoparticles are collected on the steel plate. The obtained breviscapine composition nanoparticles were vacuum-dried for 1 h to completely remove the solvent.
Embodiment 3
[0034] Breviscapine (40%), poloxamer 188 (8%), copovidone (40%), polyacrylic acid resin (12%) were mixed, and mixed solvents of absolute methanol and absolute ethanol (1 / 1. Stir at room temperature for 2 hours in V / V) to dissolve. The mass volume fraction of the polymer is 8%. When the solution is clear, transfer it to a needle tube with a needle diameter of 0.5mm. The ambient temperature is 25°C and the humidity is controlled at 40%. Next, the push speed of the push pump is 2mL / h, the receiving distance is 20cm, and 19kV high-voltage static electricity is applied between the needle and the steel plate for electrostatic spraying, and the obtained nanoparticles are collected on the steel plate. The obtained breviscapine composition nanoparticles were vacuum-dried for 1 h to completely remove the solvent.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com